BioLife Solutions, Inc. Reports Earnings Results for the Fourth Quarter and Full Year 2012
January 07, 2013 at 06:00 am EST
Share
BioLife Solutions, Inc. reported earnings results for the fourth quarter and full year 2012. For the quarter, the company reported preliminary revenue was $2.0 million and reached positive cash flow from operations.
For the year, the company announced preliminary record revenue at $5.7 million, up 105% from 2011.
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands.
BIOLIFE SOLUTIONS, INC. 
